News Alert: FDA announces new recall of interventional devices due to risk of catheter separation | Cardiovascular Business

Home

Recent Newsletters

A new approval for smallest defibrillation lead of its kind | Post-TAVR bleeding | Key details about reprocessed catheter recall

Medline recalls millions of devices due to safety risk | FDA's warning about sizing catheters | Post-TAVR bleeding events

Fighting for new cath lab safety standards | FDA confirms Impella recall | ‘Practice-changing’ research | Heart failure & PCI

New gene therapy targets a challenging condition | Big news out of Mount Sinai | First patients treated in PFA trial

TAVR Highlights: AI alerts make a big impact | When PCI can wait | A key FDA approval | New stroke prevention tech | AKI risks

New tricuspid valve OK for US trial | Drug shows clear long-term cardiac amyloid survival | Faster PFA ablations

FDA clears new software for mitral valve repair | AI-powered CCTA assessments vs. IVUS | Safety in the cath lab

Design by Adaptive Theme